Talking about treatment recommendations for breast cancer adjuvant therapy / by Roberts, Felicia D.

An electronic book accessible through the World Wide Web; click to view

Talking about treatment recommendations for breast cancer adjuvant therapy / by Roberts, Felicia D.

An electronic book accessible through the World Wide Web; click to view

Synopsis of Key Gynecologic Oncology Trials. by Renz, Malte

Table of Contents: “…Preface Uterine Malignancies Endometrial Carcinoma Studies addressing surgical treatment Lymph node assessment Studies addressing adjuvant therapy Radiation Chemoradiation Chemotherapy Studies addressing treatment of recurrent endometrial carcinoma Hormonal therapy Chemotherapy Targeted therapy Immunotherapy Uterine Carcinosarcoma Studies addressing prognosticators Studies addressing adjuvant treatment Studies addressing treatment of advanced/ recurrent uterine carcinosarcoma Uterine Leiomyosarcoma Studies addressing adjuvant treatment of early stage uterine leiomyosarcoma Studies addressing treatment of advanced uterine leiomyosarcoma References Ovarian Malignancies Epithelial ovarian cancer (EOC) Studies addressing upfront surgery Studies addressing adjuvant therapy Studies addressing neoadjuvant therapy Studies addressing prediction of debulking Studies addressing time point of treatment of recurrence Studies addressing treatment of recurrent ovarian cancer, platinum-sensitive Chemotherapy and targeted therapy Secondary debulking surgery Studies addressing treatment of recurrent ovarian cancer, platinum-resistant Chemotherapy and targeted therapy Immunotherapy Mucinous epithelial ovarian cancer Ovarian Germ Cell Tumors (GCT) Ovarian Sex Cord-Stromal Tumors (SCT) References Cervical Cancer Studies addressing surgical treatment Studies addressing adjuvant therapy Studies addressing primary chemoradiation therapy Studies addressing treatment of recurrent or metastatic cervical cancer Chemotherapy and targeted therapy Immunotherapy References Vulvar Cancer Studies addressing surgical treatment Lymph node assessment Studies addressing chemoradiation of advanced vulvar cancer References Gestational Trophoblastic Neoplasia (GTN) Studies addressing surgical treatment Studies addressing chemotherapy in low-risk GTN Studies addressing (chemo)therapy in high-risk GTN References Glossary…”
Taylor & Francis
OCLC metadata license agreement

Synopsis of Key Gynecologic Oncology Trials. by Renz, Malte

Table of Contents: “…Preface Uterine Malignancies Endometrial Carcinoma Studies addressing surgical treatment Lymph node assessment Studies addressing adjuvant therapy Radiation Chemoradiation Chemotherapy Studies addressing treatment of recurrent endometrial carcinoma Hormonal therapy Chemotherapy Targeted therapy Immunotherapy Uterine Carcinosarcoma Studies addressing prognosticators Studies addressing adjuvant treatment Studies addressing treatment of advanced/ recurrent uterine carcinosarcoma Uterine Leiomyosarcoma Studies addressing adjuvant treatment of early stage uterine leiomyosarcoma Studies addressing treatment of advanced uterine leiomyosarcoma References Ovarian Malignancies Epithelial ovarian cancer (EOC) Studies addressing upfront surgery Studies addressing adjuvant therapy Studies addressing neoadjuvant therapy Studies addressing prediction of debulking Studies addressing time point of treatment of recurrence Studies addressing treatment of recurrent ovarian cancer, platinum-sensitive Chemotherapy and targeted therapy Secondary debulking surgery Studies addressing treatment of recurrent ovarian cancer, platinum-resistant Chemotherapy and targeted therapy Immunotherapy Mucinous epithelial ovarian cancer Ovarian Germ Cell Tumors (GCT) Ovarian Sex Cord-Stromal Tumors (SCT) References Cervical Cancer Studies addressing surgical treatment Studies addressing adjuvant therapy Studies addressing primary chemoradiation therapy Studies addressing treatment of recurrent or metastatic cervical cancer Chemotherapy and targeted therapy Immunotherapy References Vulvar Cancer Studies addressing surgical treatment Lymph node assessment Studies addressing chemoradiation of advanced vulvar cancer References Gestational Trophoblastic Neoplasia (GTN) Studies addressing surgical treatment Studies addressing chemotherapy in low-risk GTN Studies addressing (chemo)therapy in high-risk GTN References Glossary…”
Taylor & Francis
OCLC metadata license agreement

Clinical applications of molecular imaging imaging to guide cancer therapy /

Table of Contents: “…Contents: Anatomic vs. functional imaging -- Functional imaging modalities -- PET/CT -- Radiotracer imaging -- Existing cancer imaging paradigm -- A new paradigm for cancer imaging -- Imaging and targeted therapy -- Biomarker imaging -- ER expression and breast cancer endocrine therapy -- Hypoxia-specific treatment -- Biologic events in response to successful cancer therapy -- Thymidine incorporation pathways -- Bone metastasis response monitoring -- FDG PET vs. bone scan -- Neo-adjuvant therapy of breast cancer -- Molecular imaging is a tool for measuring in vivo biology -- Changes in breast cancer metabolism and blood flow predict pathologic response -- Clinical trial of novel molecular imaging probes for cancer -- ACRIN experimental imaging sciences committee.…”
Get full text
Series

Clinical applications of molecular imaging imaging to guide cancer therapy /

Table of Contents: “…Contents: Anatomic vs. functional imaging -- Functional imaging modalities -- PET/CT -- Radiotracer imaging -- Existing cancer imaging paradigm -- A new paradigm for cancer imaging -- Imaging and targeted therapy -- Biomarker imaging -- ER expression and breast cancer endocrine therapy -- Hypoxia-specific treatment -- Biologic events in response to successful cancer therapy -- Thymidine incorporation pathways -- Bone metastasis response monitoring -- FDG PET vs. bone scan -- Neo-adjuvant therapy of breast cancer -- Molecular imaging is a tool for measuring in vivo biology -- Changes in breast cancer metabolism and blood flow predict pathologic response -- Clinical trial of novel molecular imaging probes for cancer -- ACRIN experimental imaging sciences committee.…”
Get full text
Series

Clinical applications of molecular imaging imaging to guide cancer therapy /

Table of Contents: “…Contents: Anatomic vs. functional imaging -- Functional imaging modalities -- PET/CT -- Radiotracer imaging -- Existing cancer imaging paradigm -- A new paradigm for cancer imaging -- Imaging and targeted therapy -- Biomarker imaging -- ER expression and breast cancer endocrine therapy -- Hypoxia-specific treatment -- Biologic events in response to successful cancer therapy -- Thymidine incorporation pathways -- Bone metastasis response monitoring -- FDG PET vs. bone scan -- Neo-adjuvant therapy of breast cancer -- Molecular imaging is a tool for measuring in vivo biology -- Changes in breast cancer metabolism and blood flow predict pathologic response -- Clinical trial of novel molecular imaging probes for cancer -- ACRIN experimental imaging sciences committee.…”
Get full text
Series

Bevacizumab the first FDA-approved angiogenesis inhibitor in the treatment of non-small cell lung cancer /

Table of Contents: “…Contents: Lung cancer incidence -- Survival by treatment group -- Selected trials of novel agents + chemotherapy -- Bevacizumab -- Vascular Endothelial Growth Factor (VEGF) -- Principles of angiogenesis -- Bevacizumab in NSCLC: not for everybody -- Randomized phase II trial of Paclitaxel/Carboplatin with/without Bevacizumab in NSCLC -- Hemorrhagic events -- Example of tumor cavitation in lung following treatment with chemotherapy and Bevacizumab -- Patient haracteristics -- Response rates -- Hematologic and non-hematologic toxicity -- Treatment related deaths -- Efficacy by gender and age -- NCCN pactice guidelines in oncology-v.2.2008 -- AVAiL: phase III trial of Bevacizumab + Gemcitabine and Cisplatin in advanced non|squamous cell NSCLC -- Second line therapy for advanced NSCLC: the role of Bevacizumab -- Adjuvant therapy in NSCLC -- Can a broader range of patients be safely treated with Bevacizumab? …”
Get full text
Series

Bevacizumab the first FDA-approved angiogenesis inhibitor in the treatment of non-small cell lung cancer /

Table of Contents: “…Contents: Lung cancer incidence -- Survival by treatment group -- Selected trials of novel agents + chemotherapy -- Bevacizumab -- Vascular Endothelial Growth Factor (VEGF) -- Principles of angiogenesis -- Bevacizumab in NSCLC: not for everybody -- Randomized phase II trial of Paclitaxel/Carboplatin with/without Bevacizumab in NSCLC -- Hemorrhagic events -- Example of tumor cavitation in lung following treatment with chemotherapy and Bevacizumab -- Patient haracteristics -- Response rates -- Hematologic and non-hematologic toxicity -- Treatment related deaths -- Efficacy by gender and age -- NCCN pactice guidelines in oncology-v.2.2008 -- AVAiL: phase III trial of Bevacizumab + Gemcitabine and Cisplatin in advanced non|squamous cell NSCLC -- Second line therapy for advanced NSCLC: the role of Bevacizumab -- Adjuvant therapy in NSCLC -- Can a broader range of patients be safely treated with Bevacizumab? …”
Get full text
Series

Bevacizumab the first FDA-approved angiogenesis inhibitor in the treatment of non-small cell lung cancer /

Table of Contents: “…Contents: Lung cancer incidence -- Survival by treatment group -- Selected trials of novel agents + chemotherapy -- Bevacizumab -- Vascular Endothelial Growth Factor (VEGF) -- Principles of angiogenesis -- Bevacizumab in NSCLC: not for everybody -- Randomized phase II trial of Paclitaxel/Carboplatin with/without Bevacizumab in NSCLC -- Hemorrhagic events -- Example of tumor cavitation in lung following treatment with chemotherapy and Bevacizumab -- Patient haracteristics -- Response rates -- Hematologic and non-hematologic toxicity -- Treatment related deaths -- Efficacy by gender and age -- NCCN pactice guidelines in oncology-v.2.2008 -- AVAiL: phase III trial of Bevacizumab + Gemcitabine and Cisplatin in advanced non|squamous cell NSCLC -- Second line therapy for advanced NSCLC: the role of Bevacizumab -- Adjuvant therapy in NSCLC -- Can a broader range of patients be safely treated with Bevacizumab? …”
Get full text
Series

Herbal radiomodulators applications in medicine, homeland defence and space /

Table of Contents: “…Uma Devi -- The radiosensitizer hypericin as adjuvant therapy in the treatment of central nervous system tumours / Toba Niazi and William T. …”
An electronic book accessible through the World Wide Web; click to view

Herbal radiomodulators applications in medicine, homeland defence and space /

Table of Contents: “…Uma Devi -- The radiosensitizer hypericin as adjuvant therapy in the treatment of central nervous system tumours / Toba Niazi and William T. …”
An electronic book accessible through the World Wide Web; click to view